HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intravenous phentolamine test: diagnostic and prognostic use in reflex sympathetic dystrophy.

Abstract
In some patients, ongoing and evoked neurogenic pain is relieved by pharmacological or destructive block of the sympathetic innervation of the affected part. In others, sympatholysis is ineffective. The present report shows that these two groups of patients can be distinguished by a safe and simple diagnostic test. Individuals in whom the pain was transiently relieved by intravenous phentolamine (Regitine) were very likely to respond favourably to subsequent sympatholytic treatment with i.v. regional guanethidine. Individuals in whom the phentolamine test was negative did not enjoy pain relief from this type of sympatholysis.
AuthorsStaffan Arnér
JournalPain (Pain) Vol. 46 Issue 1 Pg. 17-22 (Jul 1991) ISSN: 0304-3959 [Print] United States
PMID1896205 (Publication Type: Journal Article)
Chemical References
  • Phentolamine
  • Guanethidine
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Child
  • Female
  • Guanethidine (administration & dosage)
  • Humans
  • Injections, Intravenous
  • Male
  • Middle Aged
  • Pain (drug therapy, physiopathology)
  • Phentolamine (administration & dosage)
  • Prognosis
  • Reflex Sympathetic Dystrophy (diagnosis, drug therapy, physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: